Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Stock Markets Analysis & Opinion

Contribute
Plunger (Burt Coons)
Time To Get Serious About Silver By Plunger (Burt Coons) - Feb 15, 2018 3

In this post I'm going to take a serious look at silver. I believe the chartology is beginning to speak to us, signaling a huge opportunity that is setting up right now for those who can be a little...

Zacks Investment Research
Buy These 3 Airline Stocks Soaring Amid Profit Sharing By Zacks Investment Research - Feb 15, 2018

Delta Air Lines (NYSE:DAL) announced on Valentine’s Day that the company is set to pay out more than $1 billion in profit sharing to its employees as part of its continued program to spread...

The Gold Report
Allegiant Gold Begins Major Nevada Operations By The Gold Report - Feb 15, 2018

Columbus Gold Corp. (TO:CGT; OTC:CGTFF) made an intelligent business decision when they determined they should vend their non-core assets into a new company. They are retaining substantial ownership...

Investment U
Is This Only the First Correction of 2018? By Investment U - Feb 15, 2018

If the bull run that began in March 2009 is still alive and kicking, it will officially become the longest in history.As you can see in the chart below, since rising from the rubble of the financial...

Zacks Investment Research
Zoetis (ZTS) Beats On Q4 Earnings & Sales, Gives 2018 View By Zacks Investment Research - Feb 14, 2018

Zoetis Inc. (NYSE:ZTS) posted fourth-quarter 2017 adjusted earnings of 69 cents per share (excluding one-time items and a provisional net tax charge of $212 million related to recently enacted tax...

Zacks Investment Research
Nektar, Bristol-Myers Tie-Up For Cancer Combos Drives Stock By Zacks Investment Research - Feb 14, 2018

Nektar Therapeutics' (NASDAQ:NKTR) shares increased more than 11% on Feb 14 after the company announced a global strategic collaboration agreement with Bristol-Myers Squibb (NYSE:BMY) . Per the...

Zacks Investment Research
Agios (AGIO) Q4 Loss Wider Than Expected, Revenues Slump Y/Y By Zacks Investment Research - Feb 14, 2018

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) posted fourth-quarter 2017 loss of $1.81 per share, wider than both the Zacks Consensus Estimate of a loss of $1.65 and the year-ago loss of $1.34.Total...

Zacks Investment Research
Sun Life's (SLF) Q4 Earnings Grow On Solid Wealth Businesses By Zacks Investment Research - Feb 14, 2018

Sun Life Financial Inc. (TO:SLF) reported fourth-quarter 2017 underlying net income of $404 million (C$641 million), up 14.5% year over year. This improvement was driven by wealth businesses and a...

Zacks Investment Research
What's In The Offing For Concho (CXO) This Earnings Season? By Zacks Investment Research - Feb 14, 2018

Concho Resources Inc. (NYSE:CXO) , a more than $20-billion market cap energy company, is set to release fourth-quarter 2017 financial results after the closing bell on Feb 20, 2018.Last quarter, the...

Zacks Investment Research
Avon (AVP) Tops Q4 Earnings Despite Soft Sales, Stock Up By Zacks Investment Research - Feb 14, 2018

Avon Products Inc. (NYSE:AVP) reported positive earnings surprise in fourth-quarter 2017, following five straight quarters of negative surprise. However, revenues returned to negative surprise trend...

Zacks Investment Research
Waste Management (WM) Tops Q4 Earnings Estimates, View Solid By Zacks Investment Research - Feb 14, 2018

Waste Management, Inc. (NYSE:WM) reported strong fourth-quarter 2017 results with healthy year-over-year increase in revenues and earnings.Adjusted earnings for the quarter were 85 cents per share...

Zacks Investment Research
Kimco Realty (KIM) Q4 FFO Meets Estimates, Occupancy Rises By Zacks Investment Research - Feb 14, 2018

Retail real estate investment trust (REIT) Kimco Realty Corp.’s (NYSE:KIM) fourth-quarter 2017 funds from operations (FFO) came in at 38 cents per share, in line with Zacks Consensus Estimate....

Zacks Investment Research
Soft North American Sales To Hit Coca-Cola (KO) Q4 Earnings By Zacks Investment Research - Feb 14, 2018

Revenues of The Coca-Cola Company’s (NYSE:KO) North America segment, comprising about 30% of its topline, are expected to decline in the fourth quarter of 2017, when it reports on Friday, Feb...

Zacks Investment Research
Here's Why Teva Pharma Stock Is Soaring Today By Zacks Investment Research - Feb 14, 2018

Shares of Teva Pharmaceuticals (NYSE:TEVA) gained more than 10% in early morning trading Thursday after news emerged Wednesday that Warren Buffett’s Berkshire Hathaway BRK.B took a massive...

Zacks Investment Research
Equinix (EQIX) Tops Q4 AFFO & Revenue Estimates, Guides Well By Zacks Investment Research - Feb 14, 2018

Equinix Inc. (NASDAQ:EQIX) posted better-than-expected fourth-quarter 2017 results, wherein the top and bottom lines surpassed the Zacks Consensus Estimate and increased from the year-ago quarter as...

Continue with Apple
Continue with Google
or
Sign up with Email